104 related articles for article (PubMed ID: 38951097)
1. [Advances in the specific treatments of Gaucher disease].
Meng Y
Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):702-711. PubMed ID: 38951097
[TBL] [Abstract][Full Text] [Related]
2. [Gaucher Disease].
Okuyama T
Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
[TBL] [Abstract][Full Text] [Related]
3. Does enzyme replacement therapy enhance brain-derived neurotrophic factor expression in Gaucher disease?
Agilli M; Ekinci S; Fidan G
J Neuroimmunol; 2015 Feb; 279():39. PubMed ID: 25669998
[No Abstract] [Full Text] [Related]
4. Does enzyme replacement therapy enhance brain-derived neurotrophic factor expression in Gaucher disease?
Vairo F; Sperb-Ludwig F; Wilke M; Michellin-Tirelli K; Netto C; Camargo Neto E; Schwartz IV
J Neuroimmunol; 2015 Jun; 283():63. PubMed ID: 26004158
[No Abstract] [Full Text] [Related]
5. [Enzyme replacement therapy in adult patients with type I Gaucher disease].
Ponomarev RV; Lukina EA
Ter Arkh; 2019 Jul; 91(7):127-131. PubMed ID: 32598746
[TBL] [Abstract][Full Text] [Related]
6. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
[TBL] [Abstract][Full Text] [Related]
7. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
Pastores GM
Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
[TBL] [Abstract][Full Text] [Related]
8. Therapy for Gaucher disease: don't stop thinking about tomorrow.
Sidransky E; LaMarca ME; Ginns EI
Mol Genet Metab; 2007 Feb; 90(2):122-5. PubMed ID: 17084653
[TBL] [Abstract][Full Text] [Related]
9. Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
Donald A; Björkvall CK; Vellodi A; ; Cox TM; Hughes D; Jones SA; Wynn R; Machaczka M
Orphanet J Rare Dis; 2022 Jun; 17(1):234. PubMed ID: 35717194
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy.
Roth KS
Clin Pediatr (Phila); 1997 Mar; 36(3):147-8. PubMed ID: 9078416
[No Abstract] [Full Text] [Related]
11. Gaucher disease and β-thalassemia: A rare coinheritance.
Makis A; Tzoufi M; Pappa E; Kyrochristos I; Zikou A; Xydis V; Argyropoulou MI; Chaliasos N
Blood Cells Mol Dis; 2017 Jun; 65():35-37. PubMed ID: 28458077
[No Abstract] [Full Text] [Related]
12. Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014.
Barranger JA; Brady RO; Grabowski GA; Mankin H; Mistry PK; Weinreb NJ
Am J Hematol; 2014 May; 89(5):457-8. PubMed ID: 24488939
[No Abstract] [Full Text] [Related]
13. Gaucher's disease. Enzyme therapy is not enough.
Grabowski GA
Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
[No Abstract] [Full Text] [Related]
14. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.
Camou F; Viallard JF
Blood Cells Mol Dis; 2012 Jan; 48(1):51-2. PubMed ID: 21983348
[No Abstract] [Full Text] [Related]
15. Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience.
Cravo R; Rotman V; Oliveira PMN; Defendi HGT; Conceição DA; Xavier JR; Chertkoff R; Noronha TG; Maia MLS
Blood Cells Mol Dis; 2018 Feb; 68():160-162. PubMed ID: 28131618
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor expression increases after enzyme replacement therapy in Gaucher disease.
Vairo F; Sperb-Ludwig F; Wilke M; Michellin-Tirelli K; Netto C; Neto EC; Doederlein Schwartz IV
J Neuroimmunol; 2015 Jan; 278():190-3. PubMed ID: 25468270
[TBL] [Abstract][Full Text] [Related]
17. Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
Amato D; Patterson MA
J Med Case Rep; 2018 Jan; 12(1):19. PubMed ID: 29373994
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Gaucher Disease With Matched Sibling Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.
Chavananon S; Sripornsawan P; Songthawee N; Chotsampancharoen T
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1153-e1155. PubMed ID: 33661172
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement and substrate reduction therapy for Gaucher disease.
Shemesh E; Deroma L; Bembi B; Deegan P; Hollak C; Weinreb NJ; Cox TM
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010324. PubMed ID: 25812601
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns from 647 patients with Gaucher disease: An analysis from the Gaucher Outcome Survey.
Deegan P; Fernandez-Sasso D; Giraldo P; Lau H; Panahloo Z; Zimran A
Blood Cells Mol Dis; 2018 Feb; 68():218-225. PubMed ID: 27829541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
